Egyptian Chinese University
Cairo, 11757, Egypt
NCT Number: NCT07037342
The study aims to compare the immediate effects of manual needle acupuncture and electroacupuncture on the explosive force production of quadriceps in asymptomatic subjects. The hypothesis is that there will be no statistically significant difference between manual acupuncture and electroacupuncture on explosive force production.
Looking for future studies?
Notify Me18 year–28 year
All sexes
Interventional
Not applicable
Cairo, 11757, Egypt
the significance of the study lies in the importance of explosive force in muscular performance, and previous research suggests that acupuncture may induce Post-activation potentiation (PAP) and improve muscle strength. However, empirical data on the immediate effects of acupuncture on explosive force production are lacking.The study will involve 66 young asymptomatic subjects divided into three groups: manual acupuncture, electroacupuncture, and sham acupuncture. Explosive force will be measured using an isokinetic device immediately after acupuncture treatment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Manual acupuncture on acupoint (ST32, ST34, ST36, SP10) the needles will be inserted perpendicularly for 20 minutes.
Electro acupuncture on acupoint (ST32, ST34, ST36, and SP10) for 20 minutes.
Is a needle insertion at wrong points or non-points (locations that are not known acupuncture points)
Time frame: up to twenty minutes
Humac Norm Isokinetic dynamometer will be used for measuring explosive force performance
Egyptian Chinese University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details